Werewolf Therapeutics, Inc.HOWLNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P23
Within normal range
vs 5Y Ago
-0.4x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -11.48% |
| Q2 2025 | 0.18% |
| Q1 2025 | -16.58% |
| Q4 2024 | 25.53% |
| Q3 2024 | -17.96% |
| Q2 2024 | 18.31% |
| Q1 2024 | 33.78% |
| Q4 2023 | -10.97% |
| Q3 2023 | 13.10% |
| Q2 2023 | -18.14% |
| Q1 2023 | -26.19% |
| Q4 2022 | 21.34% |
| Q3 2022 | -5.88% |
| Q2 2022 | 26.88% |
| Q1 2022 | -18.32% |
| Q4 2021 | 36.92% |
| Q3 2021 | 34.71% |
| Q2 2021 | 50.82% |
| Q1 2021 | -8.87% |
| Q4 2020 | 9.85% |
| Q3 2020 | 27.30% |
| Q2 2020 | 36.81% |
| Q1 2020 | 0.00% |